Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834
Q3 FY21 results · Oct–Dec 2020
Camlin Fine Sciences reported revenue from operations of ₹297.92 crore (up 8.8% from Q3 FY20) and net profit of ₹19.42 crore (up 407.4% from Q3 FY20) for Q3 FY21 (Oct–Dec 2020), on a consolidated basis.
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 297.92 | 273.88 | +8.8% | 256.81 | +16.0% |
| Other income | 1.14 | 0.65 | +75.5% | 1.28 | −10.9% |
| Total income | 299.07 | 274.53 | +8.9% | 258.09 | +15.9% |
| Profit before tax | 27.81 | 14.25 | +95.1% | 17.17 | +62.0% |
| Net profit for the period | 19.42 | 3.83 | +407.4% | 9.66 | +101.0% |
| Attributable to shareholders of the company | 15.42 | 5.16 | +199.0% | 5.89 | +161.8% |
| EPS, basic (₹) | 1.26 | 0.43 | +193.0% | 0.49 | +157.1% |
| Net margin (%) | 6.5 | 1.4 | 3.8 |
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 163.64 | — | — | 146.78 | +11.5% |
| Other income | 1.42 | — | — | 1.33 | +6.8% |
| Total income | 165.06 | — | — | 148.10 | +11.4% |
| Profit before tax | 4.90 | — | — | (0.88) | Turned profit |
| Net profit for the period | 3.36 | — | — | (1.02) | Turned profit |
| EPS, basic (₹) | 0.27 | — | — | (0.08) | Turned profit |
| Net margin (%) | 2.1 | — | -0.7 |
Consolidated
- Filed with BSE
- 08 Feb 2021, 18:03 IST
- Board meeting
- 08 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Feb 2021, 18:03 IST
- Board meeting
- 08 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE